{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T07:58:31Z","timestamp":1785571111226,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Health Commission of Sichuan Province Medical Science and Technology Program","award":["No.23LCYJ009"],"award-info":[{"award-number":["No.23LCYJ009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12509-z","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T07:39:20Z","timestamp":1785569960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ellagic acid and gallic acid combination attenuates pulmonary fibrotic responses in vitro: evidence suggesting involvement of the 5-HT2B\/Ca\u00b2\u207a\/inflammatory axis"],"prefix":"10.1007","volume":"53","author":[{"given":"Chuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaolin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7698-6871","authenticated-orcid":false,"given":"Wenya","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"12509_CR1","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.molmed.2023.08.010","volume":"29","author":"T Koudstaal","year":"2023","unstructured":"Koudstaal T, Funke-Chambour M, Kreuter M, Molyneaux PL, Wijsenbeek MS (2023) Pulmonary fibrosis: from pathogenesis to clinical decision-making. Trends Mol Med 29:1076\u20131087. https:\/\/doi.org\/10.1016\/j.molmed.2023.08.010","journal-title":"Trends Mol Med"},{"key":"12509_CR2","doi-asserted-by":"publisher","unstructured":"Wen Z, Yang H, Ling H, Lin H, Chen X, Shi W-L, Song Y, Deng J (2026) Inhibition of ginsenoside Re on pulmonary fibrosis induced by bleomycin in mice: Involved in modulating the CX3CL1\/CX3CR1 axis. Eur J Med Chem Rep 16. https:\/\/doi.org\/10.1016\/j.ejmcr.2025.100319","DOI":"10.1016\/j.ejmcr.2025.100319"},{"key":"12509_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-024-08542-2","volume":"640","author":"Y Fang","year":"2025","unstructured":"Fang Y, Chung SSW, Xu L, Xue C, Liu X, Jiang D, Li R, Korogi Y, Yuan K, Saqi A, Hibshoosh H, Huang Y, Lin C-S, Takarada T, Tsukui T, Sheppard D, Sun X, Que J (2025) RUNX2 promotes fibrosis via an alveolar-to-pathological fibroblast transition. Nature 640:221\u2013230. https:\/\/doi.org\/10.1038\/s41586-024-08542-2","journal-title":"Nature"},{"key":"12509_CR4","doi-asserted-by":"publisher","unstructured":"Sun Y, Ren Y, Song L-y, Wang Y-y, Li T-g, Wu Y-l, Li L, Yang Z-s (2024) Targeting iron-metabolism:a potential therapeutic strategy for pulmonary fibrosis. Biomed Pharmacother 172. https:\/\/doi.org\/10.1016\/j.biopha.2024.116270","DOI":"10.1016\/j.biopha.2024.116270"},{"key":"12509_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2021.130509","author":"H Li","year":"2022","unstructured":"Li H, Fang W, Wang Z, Chen Y (2022) Physicochemical, biological properties, and flavour profile of Rosa roxburghii Tratt, Pyracantha fortuneana, and Rosa laevigata Michx fruits: A comprehensive review. Food Chem 366. https:\/\/doi.org\/10.1016\/j.foodchem.2021.130509","journal-title":"Food Chem 366"},{"key":"12509_CR6","doi-asserted-by":"publisher","unstructured":"Wang L, Wei T, Zheng L, Jiang F, Ma W, Lu M, Wu X, An H (2023) Recent advances on main active ingredients, pharmacological activities of Rosa roxbughii and Its development and utilization. Foods 12. https:\/\/doi.org\/10.3390\/foods12051051","DOI":"10.3390\/foods12051051"},{"key":"12509_CR7","doi-asserted-by":"publisher","unstructured":"Huang D, Li C, Chen Q, Xie X, Fu X, Chen C, Huang Q, Huang Z, Dong H (2022) Identification of polyphenols from Rosa roxburghii Tratt pomace and evaluation of in vitro and in vivo antioxidant activity. Food Chem 377. https:\/\/doi.org\/10.1016\/j.foodchem.2021.131922","DOI":"10.1016\/j.foodchem.2021.131922"},{"key":"12509_CR8","doi-asserted-by":"publisher","unstructured":"Zhang X, Sun Y, Zhang Z, Zhu X, He S, Zhou L, Huang M, Liu H (2025) A review: Extraction of active ingredients, functional properties of Rosa roxburghii Tratt pomace and its application. J Funct Foods 134. https:\/\/doi.org\/10.1016\/j.jff.2025.107051","DOI":"10.1016\/j.jff.2025.107051"},{"key":"12509_CR9","doi-asserted-by":"publisher","first-page":"12915","DOI":"10.1039\/d2fo02758e","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L, Li Y, Xia R, Zheng X, Li X, Wu S, Zhang Q, Li S, Deng Y, Yao Y, Ye T, Yin W (2022) Component analysis and anti-pulmonary fibrosis effects of Rosa sterilis juice. Food Funct 13:12915\u201312924. https:\/\/doi.org\/10.1039\/d2fo02758e","journal-title":"Food Funct"},{"key":"12509_CR10","doi-asserted-by":"publisher","unstructured":"Wang X, Zhou T, Huang S, Zhou H, Ling Y, Chen T, Zhang S, Wang W, Wu C, Yin W (2025) Screening and validation of active components in Rosa roxburghii Tratt for anti-pulmonary fibrosis based on a spectrum-effect relationship. Int Immunopharmacol 153. https:\/\/doi.org\/10.1016\/j.intimp.2025.114536","DOI":"10.1016\/j.intimp.2025.114536"},{"key":"12509_CR11","doi-asserted-by":"publisher","unstructured":"Li X, Huang K, Liu X, Ruan H, Ma L, Liang J, Cui Y, Wang Y, Wu S, Li H, Wei Y, Li Z, Gao J, Yang B, Li X, Yang G, Zhou H, Yang C (2021) Ellagic acid attenuates BLM-induced pulmonary fibrosis via inhibiting wnt signaling pathway. Front Pharmacol 12. https:\/\/doi.org\/10.3389\/fphar.2021.639574","DOI":"10.3389\/fphar.2021.639574"},{"key":"12509_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/613950","volume":"2013","author":"C-Y Chen","year":"2013","unstructured":"Chen C-Y, Chen K-C, Yang T-Y, Liu H-C, Hsu S-L (2013) Gallic Acid Induces a Reactive Oxygen Species-Provoked c-Jun NH2-Terminal Kinase-Dependent Apoptosis in Lung Fibroblasts. Evid Based Complement Alternat Med 2013:1\u201312. https:\/\/doi.org\/10.1155\/2013\/613950","journal-title":"Evid Based Complement Alternat Med"},{"key":"12509_CR13","doi-asserted-by":"publisher","unstructured":"Singh N, Nagar E, Gautam A, Kapoor H, Arora N (2023) Resveratrol mitigates miR-212-3p mediated progression of diesel exhaust-induced pulmonary fibrosis by regulating SIRT1\/FoxO3. https:\/\/doi.org\/10.1016\/j.scitotenv.2023.166063. Sci Total Environ 902","DOI":"10.1016\/j.scitotenv.2023.166063"},{"key":"12509_CR14","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1002\/ptr.7253","volume":"35","author":"Z Xue","year":"2021","unstructured":"Xue Z, Zhao F, Sang X, Qiao Y, Shao R, Wang Y, Gao S, Fan G, Zhu Y, Yang J (2021) Combination therapy of tanshinone IIA and puerarin for pulmonary fibrosis via targeting IL6-JAK2\u2010STAT3\/STAT1 signaling pathways. Phytother Res 35:5883\u20135898. https:\/\/doi.org\/10.1002\/ptr.7253","journal-title":"Phytother Res"},{"key":"12509_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11010-014-2194-0","volume":"397","author":"C Chen","year":"2014","unstructured":"Chen C, Han X, Fan F, Liu Y, Wang T, Wang J, Hu P, Ma A, Tian H (2014) Serotonin drives the activation of pulmonary artery adventitial fibroblasts and TGF-\u03b21\/Smad3-mediated fibrotic responses through 5-HT(2A) receptors. Mol Cell Biochem 397:267\u2013276. https:\/\/doi.org\/10.1007\/s11010-014-2194-0","journal-title":"Mol Cell Biochem"},{"key":"12509_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/7967868","volume":"2018","author":"J Zhang","year":"2018","unstructured":"Zhang J, Cui R, Feng Y, Gao W, Bi J, Li Z, Liu C (2018) Serotonin Exhibits Accelerated Bleomycin-Induced Pulmonary Fibrosis through TPH1 Knockout Mouse Experiments. Mediators Inflamm 2018:1\u201310. https:\/\/doi.org\/10.1155\/2018\/7967868","journal-title":"Mediators Inflamm"},{"key":"12509_CR17","doi-asserted-by":"publisher","unstructured":"Hon A, Lu M, Demer LL, Tintut Y (2026) Specific serotonin receptor antagonist reduces murine calcific atherosclerosis. Atherosclerosis 414. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120649","DOI":"10.1016\/j.atherosclerosis.2026.120649"},{"key":"12509_CR18","doi-asserted-by":"publisher","unstructured":"Song J-L, Zheng S-Y, He R-L, Gui L-X, Lin M-J, Sham JSK (2021) Serotonin and chronic hypoxic pulmonary hypertension activate a NADPH oxidase 4 and TRPM2 dependent pathway for pulmonary arterial smooth muscle cell proliferation and migration. Vascul Pharmacol 138. https:\/\/doi.org\/10.1016\/j.vph.2021.106860","DOI":"10.1016\/j.vph.2021.106860"},{"key":"12509_CR19","doi-asserted-by":"publisher","unstructured":"L\u00f6fdahl A, Tornling G, Wig\u00e9n J, Larsson-Callerfelt A-K, Wengl\u00e9n C, Westergren-Thorsson G (2020) Pathological insight into 5-HT2B receptor activation in fibrosing interstitial lung diseases. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22010225","DOI":"10.3390\/ijms22010225"},{"key":"12509_CR20","doi-asserted-by":"publisher","unstructured":"L\u00f6fdahl A, Nybom A, Wig\u00e9n J, Dellgren G, Brunnstr\u00f6m H, Wengl\u00e9n C, Westergren-Thorsson G (2023) Pulmonary 5-HT2B receptor expression in fibrotic interstitial lung diseases. Acta Histochem 125. https:\/\/doi.org\/10.1016\/j.acthis.2023.152024","DOI":"10.1016\/j.acthis.2023.152024"},{"key":"12509_CR21","doi-asserted-by":"publisher","unstructured":"L\u00f6fdahl A, Rydell-T\u00f6rm\u00e4nen K, Larsson-Callerfelt A-K, Wengl\u00e9n C, Westergren-Thorsson G (2018) Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT2B receptor antagonists in vitro \u2013 a potential pathway affecting proliferation. Sci Rep 8. https:\/\/doi.org\/10.1038\/s41598-018-20430-0","DOI":"10.1038\/s41598-018-20430-0"},{"key":"12509_CR22","doi-asserted-by":"publisher","unstructured":"Otoupalova E, Smith S, Cheng G, Thannickal VJ (2020) Oxidative stress in pulmonary fibrosis. In: Comprehensive physiology. pp 509\u2013547. https:\/\/doi.org\/10.1002\/cphy.c190017","DOI":"10.1002\/cphy.c190017"},{"key":"12509_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ctrv.2011.03.001","volume":"38","author":"C-J Weng","year":"2012","unstructured":"Weng C-J, Yen G-C (2012) Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: Phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev 38:76\u201387. https:\/\/doi.org\/10.1016\/j.ctrv.2011.03.001","journal-title":"Cancer Treat Rev"},{"key":"12509_CR24","doi-asserted-by":"publisher","unstructured":"Sergazy S, Shulgau Z, Nurgaziyev M, Nurgaziyeva A, Baurzhan M, Kairgeldina S, Gulyayev A (2026) Herbal polyphenolic mixtures as antioxidant and cytoprotective agents in respiratory diseases: Molecular mechanisms and therapeutic perspectives. Int J Mol Sci 27. https:\/\/doi.org\/10.3390\/ijms27125298","DOI":"10.3390\/ijms27125298"},{"key":"12509_CR25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1084\/jem.20101629","volume":"208","author":"C Dees","year":"2011","unstructured":"Dees C, Akhmetshina A, Zerr P, Reich N, Palumbo K, Horn A, J\u00fcngel A, Beyer C, Kr\u00f6nke G, Zwerina J, Reiter R, Alenina N, Maroteaux L, Gay S, Schett G, Distler O, Distler JHW (2011) Platelet-derived serotonin links vascular disease and tissue fibrosis. J Exp Med 208:961\u2013972. https:\/\/doi.org\/10.1084\/jem.20101629","journal-title":"J Exp Med"},{"key":"12509_CR26","doi-asserted-by":"publisher","unstructured":"L\u00f6fdahl A, Rydell-T\u00f6rm\u00e4nen K, M\u00fcller C, Martina Holst C, Thiman L, Ekstr\u00f6m G, Wengl\u00e9n C, Larsson\u2010Callerfelt AK, Westergren\u2010Thorsson G (2016) 5\u2010HT2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo. Physiol Rep 4. https:\/\/doi.org\/10.14814\/phy2.12873","DOI":"10.14814\/phy2.12873"},{"key":"12509_CR27","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s00210-020-01826-0","volume":"393","author":"G Kaur","year":"2020","unstructured":"Kaur G, Krishan P (2020) Serotonin 5HT2A receptor antagonism mediated anti-inflammatory and anti-fibrotic effect in adriamycin-induced CKD in rats. Naunyn Schmiedebergs Arch Pharmacol 393:1269\u20131279. https:\/\/doi.org\/10.1007\/s00210-020-01826-0","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"12509_CR28","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1111\/jcmm.17516","volume":"26","author":"C Yu","year":"2022","unstructured":"Yu C, Zhou Z, Huang W, Li X, Zou F, Meng X, Cai S (2022) Orai3 mediates Orai channel remodelling to activate fibroblast in pulmonary fibrosis. J Cell Mol Med 26:4974\u20134985. https:\/\/doi.org\/10.1111\/jcmm.17516","journal-title":"J Cell Mol Med"},{"key":"12509_CR29","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11046","author":"H Zhao","year":"2020","unstructured":"Zhao H, Li C, Li L, Liu J, Gao Y, Mu K, Chen D, Lu A, Ren Y, Li Z (2020) Baicalin alleviates bleomycin\u2013induced pulmonary fibrosis and fibroblast proliferation in rats via the PI3K\/AKT signaling pathway. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2020.11046","journal-title":"Mol Med Rep"},{"key":"12509_CR30","doi-asserted-by":"publisher","unstructured":"Lin Y, Song Y, Zhang Y, Shi M, Hou A, Han S (2023) NFAT signaling dysregulation in cancer: Emerging roles in cancer stem cells. Biomed Pharmacother 165. https:\/\/doi.org\/10.1016\/j.biopha.2023.115167","DOI":"10.1016\/j.biopha.2023.115167"},{"key":"12509_CR31","doi-asserted-by":"publisher","unstructured":"Rinne A, Pluteanu F (2024) Ca2\u2009+\u2009signaling in cardiovascular fibroblasts. Biomolecules 14. https:\/\/doi.org\/10.3390\/biom14111365","DOI":"10.3390\/biom14111365"},{"key":"12509_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G, Dedhar S, Derynck R, Ford HL, Fuxe J, Garc\u00eda de Herreros A, Goodall GJ, Hadjantonakis A-K, Huang RYJ, Kalcheim C, Kalluri R, Kang Y, Khew-Goodall Y, Levine H, Liu J, Longmore GD, Mani SA, Massagu\u00e9 J, Mayor R, McClay D, Mostov KE, Newgreen DF, Nieto MA, Puisieux A, Runyan R, Savagner P, Stanger B, Stemmler MP, Takahashi Y, Takeichi M, Theveneau E, Thiery JP, Thompson EW, Weinberg RA, Williams ED, Xing J, Zhou BP, Sheng G (2020) Guidelines and definitions for research on epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol 21:341\u2013352. https:\/\/doi.org\/10.1038\/s41580-020-0237-9","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12509_CR33","doi-asserted-by":"publisher","unstructured":"Niayesh-Mehr R, Kalantar M, Bontempi G, Montaldo C, Ebrahimi S, Allameh A, Babaei G, Seif F, Strippoli R (2024) The role of epithelial-mesenchymal transition in pulmonary fibrosis: lessons from idiopathic pulmonary fibrosis and COVID-19. Cell Commun Signal 22. https:\/\/doi.org\/10.1186\/s12964-024-01925-y","DOI":"10.1186\/s12964-024-01925-y"},{"key":"12509_CR34","doi-asserted-by":"publisher","unstructured":"Liu W, Xu S, Liang S, Duan C, Xu Z, Zhao L, Wen F, Li Q, Li Y, Zhang J (2022) Hypertensive vascular and cardiac remodeling protection by allicin in spontaneous hypertension rats via CaMK \u2161\/NF-\u03baB pathway. https:\/\/doi.org\/10.1016\/j.biopha.2022.113802. Biomed Pharmacother 155","DOI":"10.1016\/j.biopha.2022.113802"},{"key":"12509_CR35","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.jiph.2022.08.007","volume":"15","author":"D .Maranatha","year":"2022","unstructured":".Maranatha D, Hasan H, Bakhtiar A, Widyoningroem A, Aryati (2022) Association of TNF-\u03b1, TGF-\u03b21, amphiregulin, IL-2, and EGFR WITH pulmonary fibrosis in COVID-19. J Infect Public Health 15:1072\u20131075. https:\/\/doi.org\/10.1016\/j.jiph.2022.08.007","journal-title":"J Infect Public Health"},{"key":"12509_CR36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.intimp.2014.02.004","volume":"19","author":"NA El-Shitany","year":"2014","unstructured":"El-Shitany NA, El-Bastawissy EA, El-desoky K (2014) Ellagic acid protects against carrageenan-induced acute inflammation through inhibition of nuclear factor kappa B, inducible cyclooxygenase and proinflammatory cytokines and enhancement of interleukin-10 via an antioxidant mechanism. Int Immunopharmacol 19:290\u2013299. https:\/\/doi.org\/10.1016\/j.intimp.2014.02.004","journal-title":"Int Immunopharmacol"},{"key":"12509_CR37","doi-asserted-by":"publisher","unstructured":"Luo Z, Sun Y, Cai S, Liu H, Zhao C, Xu X, Xu A, Zhou H, Yang C, Gu X, Ai X (2025) Treatment of bleomycin-induced pulmonary fibrosis by intratracheal instillation administration of ellagic acid-loaded chitosan nanoparticles. AAPS PharmSciTech 26. https:\/\/doi.org\/10.1208\/s12249-025-03086-8","DOI":"10.1208\/s12249-025-03086-8"},{"key":"12509_CR38","doi-asserted-by":"publisher","unstructured":"Savin IA, Zenkova MA, Sen\u2019kova AV (2022) Pulmonary fibrosis as a result of acute lung inflammation: Molecular mechanisms, relevant in vivo models, prognostic and therapeutic approaches. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms232314959","DOI":"10.3390\/ijms232314959"},{"key":"12509_CR39","doi-asserted-by":"publisher","unstructured":"Ma M, Chu Z, Quan H, Li H, Zhou Y, Han Y, Li K, Pan W, Wang D-Y, Yan Y, Shu Z, Qiao Y (2025) Natural products for anti-fibrotic therapy in idiopathic pulmonary fibrosis: marine and terrestrial insights. Front Pharmacol 16. https:\/\/doi.org\/10.3389\/fphar.2025.1524654","DOI":"10.3389\/fphar.2025.1524654"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12509-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12509-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12509-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T07:39:21Z","timestamp":1785569961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12509-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12509"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12509-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"assertion":[{"value":"18 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted exclusively in vitro using the human lung adenocarcinoma cell line A549, which was commercially obtained from the American Type Culture Collection (ATCC; Manassas, VA, USA). Therefore, no animal experiments were performed in this study, and approval from an Institutional Animal Care and Use Committee (IACUC) was not required. All experiments were conducted in accordance with relevant institutional and national guidelines and regulations for laboratory biosafety.","order":4,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1321"}}